Sunshine Biopharma SBFM
NASDAQ SBFM
$2.75 +0.04 (+1.48%)
At close: Nov 9, 2026 · 4:00 PM EST

Sunshine Biopharma (SBFM) Sales of Property, Plant and Equipment (2023)

Updated

Sunshine Biopharma (SBFM) reported Sales of Property, Plant and Equipment of $293.00 for Q1 2023.

Analysis

Sunshine Biopharma (SBFM) Sales of Property, Plant and Equipment (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -4.00 Mn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Sunshine Biopharma 187,731.50 -38.90 Mn 2.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 293.00
API Access

Sunshine Biopharma Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=SBFM&period=max&api_key=YOUR_API_KEY